Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

[1]  G. Rassidakis,et al.  Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  E. Jaffe.  Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[3]  Fernando U Garcia,et al.  Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  A. Feller,et al.  Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays. , 2002, Journal of hematotherapy & stem cell research.

[5]  Zhiheng Yu,et al.  STAT1 and STAT3 mediate thrombin-induced expression of TIMP-1 in human glomerular mesangial cells. , 2002, Kidney international.

[6]  Rajiv Dhir,et al.  Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. , 2002, The Journal of urology.

[7]  I. Kawase,et al.  Cardiac-specific Activation of Signal Transducer and Activator of Transcription 3 Promotes Vascular Formation in the Heart* , 2002, The Journal of Biological Chemistry.

[8]  D. Levy,et al.  Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death , 2002, Oncogene.

[9]  Y. Fujio,et al.  Activation of Signal Transducer and Activator of Transcription 3 Protects Cardiomyocytes from Hypoxia/Reoxygenation-Induced Oxidative Stress Through the Upregulation of Manganese Superoxide Dismutase , 2001, Circulation.

[10]  Hua Yu,et al.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.

[11]  D. Venzon,et al.  Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. , 2001, Blood.

[12]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[13]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Kossakowska,et al.  Matrix Metalloproteinases and Their Tissue Inhibitors - Expression, Role and Regulation in Human Malignant Non-Hodgkin's Lymphomas , 2000, Leukemia & lymphoma.

[15]  G. Li,et al.  Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. , 1999, Cancer research.

[16]  Joshua M. Stuart,et al.  MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES , 1999 .

[17]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[18]  H. Nielsen,et al.  Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer , 1999, British Journal of Cancer.

[19]  J. Rhim,et al.  Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  P. Henriet,et al.  Tissue inhibitors of metalloproteinases (TEMP) in invasion and proliferation , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  A. Baker,et al.  Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 , 1999, British Journal of Cancer.

[22]  M. Duffy,et al.  High levels of tissue inhibitor of metalloproteinase‐1 predict poor outcome in patients with breast cancer , 1999, International journal of cancer.

[23]  M. Stetler-Stevenson,et al.  Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. , 1998, Blood.

[24]  Y. Fujio,et al.  Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.

[25]  D. Wakefield,et al.  Expression of matrix metalloproteinases by human plasma cells and B lymphocytes , 1998, European journal of immunology.

[26]  P. Rothman,et al.  Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. , 1997, Journal of immunology.

[27]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[28]  J. Fata,et al.  Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice. , 1997, Blood.

[29]  G. Marti,et al.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. , 1997, Blood.

[30]  J. Dayer,et al.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. , 1995, The Journal of clinical investigation.

[31]  H. Sato,et al.  Tax proteins of human T-cell leukemia virus type 1 and 2 induce expression of the gene encoding erythroid-potentiating activity (tissue inhibitor of metalloproteinases-1, TIMP-1). , 1994, The Journal of biological chemistry.

[32]  T. Sato,et al.  Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. , 1990, Biochemical and biophysical research communications.

[33]  T. Hayakawa.  Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): a new aspect involving osteoclastic bone resorption , 2002, Journal of Bone and Mineral Metabolism.

[34]  V. Diehl,et al.  Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. , 2002, Blood.

[35]  T. Grogan,et al.  Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. , 1999, Blood.

[36]  A. Kugler.  Matrix metalloproteinases and their inhibitors. , 1999, Anticancer research.

[37]  B. Groner,et al.  STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. , 1996, Blood.

[38]  P. Heinrich,et al.  Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. , 1995, Nucleic acids research.

[39]  A. Kossakowska,et al.  Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. , 1992, Oncology research.